These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience. Pashankar FD; Rodriguez-Galindo C; Pappo A J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404 [TBL] [Abstract][Full Text] [Related]
10. Rare cancers in childhood and adolescence in Brazil: First report of data from 19 population-based cancer registries. Balmant NV; de Souza Reis R; de Oliveira Santos M; de Camargo B; Gatta G Cancer; 2019 Aug; 125(15):2638-2646. PubMed ID: 31013367 [TBL] [Abstract][Full Text] [Related]
11. Clinical trial design for rare cancers: why a less conventional route may be required. Panageas KS Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109 [TBL] [Abstract][Full Text] [Related]
17. The challenge of very rare tumours in childhood: the Italian TREP project. Ferrari A; Bisogno G; De Salvo GL; Indolfi P; Perilongo G; Cecchetto G; ; Eur J Cancer; 2007 Mar; 43(4):654-9. PubMed ID: 17049226 [TBL] [Abstract][Full Text] [Related]
18. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Ferrari A; Brecht IB; Gatta G; Schneider DT; Orbach D; Cecchetto G; Godzinski J; Reguerre Y; Bien E; Stachowicz-Stencel T; Ost M; Magni C; Kearns P; Vassal G; Massimino M; Biondi A; Bisogno G; Trama A Eur J Cancer; 2019 Mar; 110():120-126. PubMed ID: 30785015 [TBL] [Abstract][Full Text] [Related]